Variant report

Variant	rs71361489
Chromosome Location	chr18:267496-267497
allele	A/C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	SIN3A	chr18:267339-268912	H1-hESC	embryonic stem cell:	n/a	n/a
2	MAX	chr18:267495-268686	A549	lung:	n/a	n/a
3	E2F6	chr18:267408-269008	H1-hESC	embryonic stem cell:	n/a	chr18:268065-268074 chr18:267465-267472 chr18:268051-268061 chr18:267465-267472 chr18:268063-268072 chr18:267465-267472 chr18:267530-267542
4	THAP1	chr18:267431-268307	K562	blood:	n/a	n/a
5	CREB1	chr18:267402-268516	K562	blood:	n/a	chr18:268062-268075
6	MTA3	chr18:267263-269125	GM12878	blood:	n/a	n/a
7	PML	chr18:267427-268891	GM12878	blood:	n/a	n/a
8	HCFC1	chr18:267223-269038	Hela-S3	cervix:	n/a	n/a
9	POLR2A	chr18:267483-268987	K562	blood:	n/a	n/a
10	MAX	chr18:267363-268617	ECC-1	luminal epithelium:	n/a	n/a
11	POLR2A	chr18:267486-269249	GM12892	blood:	n/a	n/a
12	CTCF	chr18:267440-267590	Caco-2	colon:	n/a	n/a
13	CREB1	chr18:267320-268724	K562	blood:	n/a	chr18:268062-268075
14	POLR2A	chr18:267400-269312	GM12892	blood:	n/a	n/a
15	MAX	chr18:267472-269099	SK-N-SH	brain:	n/a	n/a
16	POLR2A	chr18:267354-269256	HL-60	blood:	n/a	n/a
17	MXI1	chr18:267051-269186	SK-N-SH	brain:	n/a	n/a
18	POLR2A	chr18:267357-269103	HUVEC	blood vessel:	n/a	n/a
19	POLR2A	chr18:267377-269130	Hela-S3	cervix:	n/a	n/a
20	POLR2A	chr18:267277-269326	Hela-S3	cervix:	n/a	n/a
21	JUN	chr18:267058-269301	K562	blood:	n/a	chr18:268193-268203 chr18:268858-268868 chr18:268858-268868 chr18:268192-268204 chr18:268858-268868 chr18:268190-268201 chr18:268193-268204
22	MXI1	chr18:267445-268903	HepG2	liver:	n/a	n/a
23	POLR2A	chr18:267442-269391	K562	blood:	n/a	n/a
24	POLR2A	chr18:267370-269259	K562	blood:	n/a	n/a
25	POLR2A	chr18:267333-269222	GM12891	blood:	n/a	n/a
26	E2F6	chr18:267419-269093	K562	blood:	n/a	chr18:268065-268074 chr18:267465-267472 chr18:268051-268061 chr18:267465-267472 chr18:268063-268072 chr18:267465-267472 chr18:267530-267542
27	POLR2A	chr18:267446-268563	ECC-1	luminal epithelium:	n/a	n/a
28	TAF1	chr18:267483-268540	H1-neurons	neurons:	n/a	n/a
29	CREB1	chr18:267425-268446	HepG2	liver:	n/a	chr18:268062-268075
30	STAT5A	chr18:267493-268955	GM12878	blood:	n/a	chr18:267600-267612 chr18:268285-268297
31	POLR2A	chr18:267362-268567	ECC-1	luminal epithelium:	n/a	n/a
32	MAX	chr18:267430-268605	HepG2	liver:	n/a	n/a
33	POU2F2	chr18:267438-268480	GM12891	blood:	n/a	n/a
34	POLR2A	chr18:267493-269172	K562	blood:	n/a	n/a
35	HEY1	chr18:267471-268467	HepG2	liver:	n/a	chr18:268037-268052 chr18:268063-268072
36	TAF1	chr18:267494-268891	K562	blood:	n/a	n/a
37	POLR2A	chr18:267450-269926	HepG2	liver:	n/a	n/a
38	POLR2A	chr18:267341-269208	Hela-S3	cervix:	n/a	n/a
39	POLR2A	chr18:267473-269082	SK-N-SH	brain:	n/a	n/a
40	MAX	chr18:267401-268520	H1-hESC	embryonic stem cell:	n/a	n/a
41	HEY1	chr18:267326-269283	K562	blood:	n/a	chr18:268037-268052 chr18:268063-268072
42	MAX	chr18:267374-269284	K562	blood:	n/a	n/a
43	POLR2A	chr18:267463-268585	GM12878	blood:	n/a	n/a
44	TBP	chr18:267341-268922	H1-hESC	embryonic stem cell:	n/a	n/a
45	POLR2A	chr18:267202-269209	HL-60	blood:	n/a	n/a
46	CREB1	chr18:267493-268539	GM12878	blood:	n/a	chr18:268062-268075
47	RCOR1	chr18:267114-269118	IMR90	lung:	n/a	n/a
48	POLR2A	chr18:267376-268726	H1-neurons	neurons:	n/a	n/a
49	POLR2A	chr18:267490-269066	Hela-S3	cervix:	n/a	n/a
50	POLR2A	chr18:267372-269576	K562	blood:	n/a	n/a

No.	Distal block	Cell Line	Cell type
1	chr18:254095..260758-chr18:263922..270842,11	K562	blood:
2	chr18:266563..269513-chr18:596555..599263,2	K562	blood:
3	chr18:157295..159730-chr18:266988..268701,2	MCF-7	breast:
4	chr18:267460..269280-chr18:657302..659143,2	MCF-7	breast:
5	chr18:245161..246691-chr18:267290..268798,2	MCF-7	breast:
6	chr18:250843..253350-chr18:266351..269442,3	MCF-7	breast:
7	chr18:257542..263185-chr18:266000..270349,8	MCF-7	breast:
8	chr18:227929..230720-chr18:265725..267925,3	K562	blood:
9	chr18:158012..160007-chr18:265808..268303,2	MCF-7	breast:
10	chr18:110119..112537-chr18:266561..268595,2	MCF-7	breast:
11	chr18:267452..268053-chr9:134269416..134270075,2	Hela-S3	cervix:
12	chr18:249334..252987-chr18:265974..268103,4	MCF-7	breast:
13	chr18:266113..269077-chr18:710034..713387,3	K562	blood:

Variant related genes	Relation type
ENSG00000263884	TF binding region
ENSG00000132199	Chromatin interaction
ENSG00000130723	Chromatin interaction
ENSG00000176890	Chromatin interaction
ENSG00000176912	Chromatin interaction
ENSG00000079134	Chromatin interaction
ENSG00000101557	Chromatin interaction
ENSG00000263006	Chromatin interaction
ENSG00000079101	Chromatin interaction

Extended variants
information (count: 44 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:9)

rs_ID	r²[population]
rs12960380	0.83[AFR][1000 genomes];1.00[EUR][1000 genomes]
rs12965796	1.00[EUR][1000 genomes]
rs34411694	0.87[EUR][1000 genomes]
rs34855030	1.00[EUR][1000 genomes]
rs71352926	0.87[EUR][1000 genomes]
rs71352928	0.83[AFR][1000 genomes];1.00[EUR][1000 genomes]
rs71352929	0.80[AFR][1000 genomes];1.00[EUR][1000 genomes]
rs71352930	0.94[AFR][1000 genomes];1.00[EUR][1000 genomes]
rs71352931	1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:35 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv1061730	chr18:11543-322183	Weak transcription Strong transcription Enhancers Active TSS Flanking Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
2	nsv1059645	chr18:11543-326679	Weak transcription Active TSS Flanking Active TSS Enhancers ZNF genes & repeats Strong transcription Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
3	nsv576227	chr18:52933-322183	Strong transcription Weak transcription ZNF genes & repeats Enhancers Active TSS Flanking Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
4	nsv1064150	chr18:99036-321710	Genic enhancers Weak transcription Strong transcription Active TSS Enhancers Flanking Active TSS Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
5	nsv1055303	chr18:112328-304352	Strong transcription Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers Genic enhancers Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
6	nsv543527	chr18:112328-304352	Genic enhancers Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	16 gene(s)	inside rSNPs	diseases
7	nsv543530	chr18:112528-932674	Weak transcription Strong transcription Bivalent Enhancer Active TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	81 gene(s)	inside rSNPs	diseases
8	nsv1067102	chr18:112528-984688	Flanking Active TSS Weak transcription ZNF genes & repeats Enhancers Strong transcription Transcr. at gene 5' and 3' Active TSS Genic enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
9	nsv543531	chr18:112528-984688	Genic enhancers Weak transcription Active TSS Enhancers Flanking Active TSS Strong transcription Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	83 gene(s)	inside rSNPs	diseases
10	nsv1057029	chr18:141491-356238	Strong transcription Flanking Active TSS Enhancers Weak transcription Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
11	nsv1066995	chr18:141491-415027	Weak transcription Flanking Active TSS Strong transcription Enhancers Genic enhancers Active TSS ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	17 gene(s)	inside rSNPs	diseases
12	nsv1064735	chr18:141491-483651	Strong transcription Enhancers Weak transcription Active TSS Flanking Active TSS Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	18 gene(s)	inside rSNPs	diseases
13	nsv1062680	chr18:141491-549166	Weak transcription ZNF genes & repeats Flanking Active TSS Strong transcription Enhancers Bivalent Enhancer Active TSS Bivalent/Poised TSS Genic enhancers Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
14	nsv1067218	chr18:141491-603796	Weak transcription Enhancers Strong transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
15	nsv543544	chr18:141491-675519	Bivalent/Poised TSS Weak transcription Strong transcription Enhancers Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	56 gene(s)	inside rSNPs	diseases
16	nsv1064998	chr18:141491-1095845	Weak transcription Enhancers Strong transcription Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	84 gene(s)	inside rSNPs	diseases
17	nsv543545	chr18:141491-1095845	Enhancers Flanking Active TSS Strong transcription Bivalent/Poised TSS Weak transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	84 gene(s)	inside rSNPs	diseases
18	nsv531216	chr18:148763-293736	Weak transcription Active TSS Strong transcription Flanking Active TSS Enhancers Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
19	nsv532441	chr18:148763-1108997	Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers Strong transcription Bivalent Enhancer Flanking Active TSS Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	84 gene(s)	inside rSNPs	diseases
20	nsv530373	chr18:148963-533693	Weak transcription Strong transcription Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Genic enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	20 gene(s)	inside rSNPs	diseases
21	nsv482910	chr18:161390-305010	Weak transcription Flanking Active TSS Genic enhancers Strong transcription Enhancers Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
22	nsv518642	chr18:196829-331506	Weak transcription Strong transcription Flanking Active TSS Enhancers Genic enhancers ZNF genes & repeats Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
23	nsv1067432	chr18:219990-290812	Strong transcription Weak transcription Flanking Active TSS Active TSS Enhancers Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
24	nsv948987	chr18:220071-461872	Enhancers Strong transcription Weak transcription Flanking Active TSS Genic enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	15 gene(s)	inside rSNPs	diseases
25	nsv948735	chr18:220071-615394	Weak transcription Active TSS Genic enhancers Strong transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	24 gene(s)	inside rSNPs	diseases
26	nsv915747	chr18:225017-287764	Active TSS Weak transcription Strong transcription Flanking Active TSS Enhancers ZNF genes & repeats Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	12 gene(s)	inside rSNPs	diseases
27	nsv534315	chr18:225061-776966	Enhancers Weak transcription Strong transcription Genic enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	62 gene(s)	inside rSNPs	diseases
28	nsv909287	chr18:225964-677240	Genic enhancers Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription Strong transcription Bivalent/Poised TSS Bivalent Enhancer Active TSS ZNF genes & repeats Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	53 gene(s)	inside rSNPs	diseases
29	nsv1056707	chr18:231508-290812	Enhancers Active TSS Weak transcription Strong transcription Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers ZNF genes & repeats Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	12 gene(s)	inside rSNPs	diseases
30	nsv2174	chr18:240074-285087	Strong transcription Weak transcription Flanking Active TSS Enhancers Active TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region lncRNA	12 gene(s)	inside rSNPs	diseases
31	nsv1060428	chr18:252297-322289	Enhancers Flanking Active TSS Weak transcription Strong transcription Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
32	nsv543561	chr18:252297-322289	Enhancers Flanking Active TSS Active TSS Strong transcription Weak transcription Bivalent Enhancer Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases
33	nsv1058796	chr18:254290-313208	Enhancers Strong transcription Transcr. at gene 5' and 3' Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Genic enhancers Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
34	nsv543562	chr18:254290-313208	Enhancers Flanking Active TSS Active TSS Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
35	nsv1066129	chr18:258717-369148	Strong transcription Genic enhancers Enhancers Flanking Active TSS Weak transcription Active TSS Bivalent Enhancer ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	14 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:127 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr18:266200-269000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr18:266400-267600	Flanking Active TSS	K562	blood
3	chr18:266800-267600	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
4	chr18:266800-267600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
5	chr18:266800-267600	Flanking Active TSS	Dnd41	blood
6	chr18:266800-268800	Active TSS	Hela-S3	cervix
7	chr18:267000-267600	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
8	chr18:267000-267600	Flanking Active TSS	Primary T cells from cord blood	blood
9	chr18:267000-267600	Flanking Active TSS	Primary hematopoietic stem cells	blood
10	chr18:267000-267600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
11	chr18:267000-267600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
12	chr18:267000-267600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
13	chr18:267000-267600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
14	chr18:267000-267600	Flanking Active TSS	Cortex derived primary cultured neurospheres	brain
15	chr18:267000-267600	Flanking Active TSS	Duodenum Smooth Muscle	Duodenum
16	chr18:267000-267600	Flanking Active TSS	Fetal Brain Male	brain
17	chr18:267000-267600	Flanking Active TSS	Rectal Smooth Muscle	rectum
18	chr18:267000-267600	Flanking Active TSS	HUVEC	blood vessel
19	chr18:267000-267600	Flanking Active TSS	Osteobl	bone
20	chr18:267000-267800	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
21	chr18:267000-268200	Active TSS	Brain Germinal Matrix	brain
22	chr18:267000-268600	Active TSS	Fetal Thymus	thymus
23	chr18:267000-268600	Active TSS	NH-A	brain
24	chr18:267000-268800	Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr18:267000-268800	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
26	chr18:267000-268800	Active TSS	Stomach Smooth Muscle	stomach
27	chr18:267000-268800	Active TSS	NHLF	lung
28	chr18:267000-269000	Active TSS	H1 Cell Line	embryonic stem cell
29	chr18:267000-269000	Active TSS	iPS-18 Cell Line	embryonic stem cell
30	chr18:267000-269000	Active TSS	Breast Myoepithelial Primary Cells	Breast
31	chr18:267000-269000	Active TSS	HMEC	breast
32	chr18:267000-269000	Active TSS	NHDF-Ad	bronchial
33	chr18:267000-269200	Active TSS	Pancreatic Islets	Pancreatic Islet
34	chr18:267000-269200	Active TSS	A549	lung
35	chr18:267000-269600	Active TSS	ES-I3 Cell Line	embryonic stem cell
36	chr18:267000-269600	Active TSS	HUES6 Cell Line	embryonic stem cell
37	chr18:267000-269600	Active TSS	iPS-20b Cell Line	embryonic stem cell
38	chr18:267000-270000	Active TSS	HUES64 Cell Line	embryonic stem cell
39	chr18:267200-267600	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
40	chr18:267200-267600	Flanking Active TSS	Primary B cells from peripheral blood	blood
41	chr18:267200-267600	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
42	chr18:267200-267600	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
43	chr18:267200-267600	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
44	chr18:267200-267600	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
45	chr18:267200-267600	Flanking Active TSS	Primary T killer naive cells fromperipheralblood	blood
46	chr18:267200-267600	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
47	chr18:267200-267600	Flanking Active TSS	Muscle Satellite Cultured Cells	--
48	chr18:267200-267600	Flanking Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
49	chr18:267200-267600	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
50	chr18:267200-267600	Flanking Active TSS	Adipose Nuclei	Adipose

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links